Boston, Massachusetts, United States · On-site
Your Impact Alpha-9 Oncology is seeking a Senior Accountant to support the company's accounting operations, financial reporting, and monthly close processes. Reporting to the Assistant Controller, this role serves as a k…
Skills: U.S. GAAP, Month-end Close, Financial Reporting, SOX Compliance, Internal Controls
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Senior Accountant will manage monthly, quarterly, and annual close activities, including journal entries and financial reporting. They will also support internal controls, coordinate payroll, and assist with audits and process improvements.
Candidates should have a Bachelor's degree in Accounting or Finance and 3-5+ years of relevant accounting experience. Proficiency in U.S. GAAP, Microsoft Excel, and experience with NetSuite or SOX environments is preferred.
Your Impact
Alpha-9 Oncology is seeking a Senior Accountant to support the company's accounting operations, financial reporting, and monthly close processes. Reporting to the Assistant Controller, this role serves as a key contributor to the Finance organization, ensuring the accuracy, integrity, and efficiency of accounting activities while helping strengthen internal controls as the company continues to grow.
You will partner across Finance, Human Resources, and external service providers to support payroll, audits, financial reporting, and process improvements. This role offers broad exposure across the accounting function and the opportunity to help build scalable processes that support Alpha-9's continued growth.
How You’ll Contribute
The Skills You Bring
Compensation
Alpha-9 Oncology is committed to pay transparency and equitable compensation. The salary range for this position represents the Company’s good-faith estimate of base compensation at the time of posting, established using external market data and internal benchmarking. Final compensation will be determined based on experience, qualifications, education, and internal equity.
This role is eligible for an annual bonus, equity participation, and a comprehensive benefits package.
Alpha-9 Oncology is a clinical-stage biotechnology company pioneering radiopharmaceutical innovation for solid tumors. Our proprietary scaffolds, composed of optimized binders, linkers, chelators, and radioisotopes, enable targeted radiation delivery to cancer cells, minimizing harm to surrounding healthy tissue. Focusing on innovative targeting moieties, we develop molecules tailored for precise tumor targeting.
Our comprehensive platform integrates imaging and therapeutic studies to ensure effective radiation delivery and improved patient outcomes. With a robust pipeline entering clinical trials and strong support from leading healthcare investors, Alpha-9 is positioned for rapid growth and advancement in cancer therapy.
More about Alpha-9 Oncology
Alpha-9 Oncology is committed to fostering a diverse and inclusive workplace and is proud to be an Equal Opportunity Employer. We provide employment opportunities to all qualified applicants without regard to race, ethnicity, religion, age, sex, gender identity or expression, sexual orientation, disability, marital status, family status, national origin, or any other characteristic protected by applicable federal, provincial, or local laws where we operate.
We are dedicated to providing reasonable accommodations to qualified applicants and employees to ensure that everyone can perform their essential job functions in an inclusive environment. For inquiries regarding accommodations in the hiring process or for current employees, please contact a member from our Talent Acquisition team.
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
Offices: Boston, Massachusetts, US · Vancouver, BC, CA
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
Offices: Boston, Massachusetts, US · Vancouver, BC, CA
